GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corline Biomedical AB (OSTO:CLBIO) » Definitions » Cyclically Adjusted Revenue per Share

Corline Biomedical AB (OSTO:CLBIO) Cyclically Adjusted Revenue per Share : kr0.37 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Corline Biomedical AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Corline Biomedical AB's adjusted revenue per share for the three months ended in Mar. 2024 was kr0.174. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr0.37 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-04), Corline Biomedical AB's current stock price is kr10.95. Corline Biomedical AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr0.37. Corline Biomedical AB's Cyclically Adjusted PS Ratio of today is 29.59.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Corline Biomedical AB was 32.43. The lowest was 27.30. And the median was 28.51.


Corline Biomedical AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Corline Biomedical AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corline Biomedical AB Cyclically Adjusted Revenue per Share Chart

Corline Biomedical AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Corline Biomedical AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.37

Competitive Comparison of Corline Biomedical AB's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Corline Biomedical AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corline Biomedical AB's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corline Biomedical AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Corline Biomedical AB's Cyclically Adjusted PS Ratio falls into.



Corline Biomedical AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Corline Biomedical AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.174/132.2054*132.2054
=0.174

Current CPI (Mar. 2024) = 132.2054.

Corline Biomedical AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 0.000 100.541 0.000
201406 0.050 100.432 0.066
201409 0.026 100.161 0.034
201412 0.068 100.225 0.090
201503 0.011 99.950 0.015
201506 0.061 99.995 0.081
201509 0.023 100.228 0.030
201512 0.016 100.276 0.021
201603 0.022 100.751 0.029
201606 0.030 101.019 0.039
201609 0.012 101.138 0.016
201612 0.016 102.022 0.021
201703 0.017 102.022 0.022
201706 0.008 102.752 0.010
201709 0.009 103.279 0.012
201712 0.013 103.793 0.017
201803 0.021 103.962 0.027
201806 0.023 104.875 0.029
201809 0.022 105.679 0.028
201812 0.034 105.912 0.042
201903 0.009 105.886 0.011
201906 0.022 106.742 0.027
201909 0.008 107.214 0.010
201912 0.024 107.766 0.029
202003 0.011 106.563 0.014
202006 0.036 107.498 0.044
202009 0.022 107.635 0.027
202012 0.152 108.296 0.186
202103 0.087 108.360 0.106
202106 0.063 108.928 0.076
202109 0.045 110.338 0.054
202112 0.151 112.486 0.177
202203 0.143 114.825 0.165
202206 0.242 118.384 0.270
202209 0.327 122.296 0.353
202212 0.384 126.365 0.402
202303 0.344 127.042 0.358
202306 0.283 129.407 0.289
202309 0.247 130.224 0.251
202403 0.174 132.205 0.174

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Corline Biomedical AB  (OSTO:CLBIO) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Corline Biomedical AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=10.95/0.37
=29.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Corline Biomedical AB was 32.43. The lowest was 27.30. And the median was 28.51.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Corline Biomedical AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Corline Biomedical AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Corline Biomedical AB (OSTO:CLBIO) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.

Corline Biomedical AB (OSTO:CLBIO) Headlines

No Headlines